Back to Home

Companies in #Organ transplantation

Found 1 company operating in this sector.

Clinical-stage biopharmaceutical company pioneering Top-Down Drug Discovery, which leverages evolutionary insights from fungi to develop next-generation precision medicines. In August 2026 it raised a combined $263 million (Series D + Series F) to support the clinical program for LIFE-001, under development to prevent organ failure.

Sector:AI-Driven Drug Discovery / Small Molecule Pharma
HQ:Cambridge, Massachusetts, USA